Third-generation beta-blockers in the treatment of cardiovascular diseases
| dc.contributor.advisor | Szentmiklósi, József András | |
| dc.contributor.advisordept | Department of Pharmacology and Pharmacotherapy | hu_HU |
| dc.contributor.author | Brynleifsson, Magnús Ari | |
| dc.contributor.department | DE--Általános Orvostudományi Kar | hu_HU |
| dc.contributor.opponent | Drimba, László | |
| dc.contributor.opponent | Pórszász, Róbert | |
| dc.contributor.opponentdept | Kenézy Kórház, Aneszteziológiai és Intenziv Therápiás Osztály | hu_HU |
| dc.contributor.opponentdept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | hu_HU |
| dc.date.accessioned | 2022-01-19T11:09:00Z | |
| dc.date.available | 2022-01-19T11:09:00Z | |
| dc.date.created | 2021-09 | |
| dc.description.abstract | Overview of the pharmacology, and use of third-generation beta-blockers in the treatment of cardiovascular diseases, and a comparison between third-generation beta-blockers and older generations in the treatment of cardiovascular diseases. The third-generation beta-blockers have an additional vasodilatory effect that is not seen in the 1st- or 2nd-generations as well as other properties that might give them an advantage in the treatment of cardiovascular diseases in certain patient groups. | hu_HU |
| dc.description.course | általános orvos | hu_HU |
| dc.description.courselang | angol | hu_HU |
| dc.description.degree | egységes, osztatlan | hu_HU |
| dc.format.extent | 39 | hu_HU |
| dc.identifier.uri | http://hdl.handle.net/2437/328024 | |
| dc.language.iso | en | hu_HU |
| dc.subject | Third-generation beta-blockers | hu_HU |
| dc.subject | Carvedilol | hu_HU |
| dc.subject | Nebivolol | hu_HU |
| dc.subject | Labetalol | hu_HU |
| dc.subject.dspace | DEENK Témalista::Orvostudomány | hu_HU |
| dc.title | Third-generation beta-blockers in the treatment of cardiovascular diseases | hu_HU |